β€’
Mar 31, 2021

Johnson & Johnson Q1 2021 Earnings Report

Johnson & Johnson reported strong first-quarter results driven by the Pharmaceutical business and Medical Devices recovery.

Key Takeaways

Johnson & Johnson's first-quarter sales reached $22.3 billion, reflecting a 7.9% growth. The company's EPS increased by 6.9% to $2.32, with adjusted EPS rising by 12.6% to $2.59. The company also increased its full-year guidance for adjusted operational sales and EPS growth.

First Quarter Sales reached $22.3 Billion, reflecting a strong growth of 7.9%.

First Quarter EPS increased 6.9% to $2.32; adjusted EPS increased 12.6% to $2.59.

Company increased 2021 Full-Year guidance for adjusted operational sales growth to 9.3%.

Company increased 2021 Full-Year guidance for adjusted operational EPS growth to 16.8%.

Total Revenue
$22.3B
Previous year: $20.7B
+7.9%
EPS
$2.59
Previous year: $2.3
+12.6%

Johnson & Johnson

Johnson & Johnson

Forward Guidance

Johnson & Johnson increased its 2021 full-year guidance for adjusted operational sales growth to 9.3% and adjusted operational EPS growth to 16.8% at the midpoint.